Logo

circulating miRNA

European Consortium Seeks to Develop Liquid Biopsy Test for Prostate, Testicular Cancer
Premium

The European Commission awarded a consortium of private companies and academic researchers €759,000 recently to carry out their plans.

DiamiR Wins $3.9M in NIH Funding for Neurological Disease Diagnostic Development

The two grants awarded will support DiamiR's development of microRNA diagnostics for mild cognitive impairment, Alzheimer's disease, and Rett syndrome.

MiR Scientific Validates Urine-Based Cancer Tests, Awaits NY State Approval
Premium

The firm recently published a study describing three assays for prostate cancer and reporting their sensitivity and specificity in case-control cohort.

Blood-Based MicroRNA Signatures Can Distinguish Individuals With Lung Cancer

A retrospective cohort study uncovered microRNA signatures that could tell lung cancer patients apart from others, including patients with other, non-tumor lung conditions.

MiR Scientific Prepares to Launch Tests for Prostate, Bladder Cancer
Premium

The company is seeking NY State approval for its lab, which would allow it to offer both tests as LDTs, hopefully by the end of this year or early next.

Dec 6, 2018

Cancer Early Detection Firm Ark Launches With $40M Series A Investment

Sep 19, 2018

New Technique Allows Sequencing of Short RNAs From Dried Blood Spots, Other Small Samples
Premium

Jul 20, 2018

MiR Scientific Prepares Launch of First Clinical Cancer Test, Buoyed by New Data
Premium

Apr 10, 2018

Quadrant Biosciences Licenses SUNY, Penn State Epigenetic Biomarkers for Neuro Diseases

Nov 14, 2017

Dana-Farber Team Developing MicroRNA Liquid Biopsy to Diagnose Ovarian Cancer
Premium

Mar 10, 2017

Chinese Startup HeliTec Launches Large Liquid Biopsy Study

Nov 11, 2016

Circulating Maternal MicroRNAs Distinguish Infants Affected by Fetal Alcohol Syndrome

Sep 6, 2016

Prostate Cancer Grades Can Be Distinguished Using MicroRNA Signature, Study Finds

Mar 9, 2016

Startup Miroculus Shares Vision for Rapid, Inexpensive miRNA Diagnostics at Tri-Con
Premium

Dec 31, 2015

Early Data Encouraging for Development of Blood-Based MicroRNA Test for Germ Cell Cancers
Premium

Nov 6, 2015

HTG Updates NGS Assay Pipeline; Academic Partners Working on microRNA-Based Ovarian Cancer Subtyping

Aug 28, 2015

Moffitt Team Uses Nanostring Tech to ID MiRNA Signature for Early Pancreatic Cancer Detection
Premium

Jul 17, 2015

With NCI Funding, Baylor Team Developing microRNA-Based Colorectal Cancer Screen
Premium

May 6, 2015

With NCI Grant, Librede Looks to Develop Nanopore-Based microRNA Diagnostic
Premium

Feb 27, 2014

Singapore's MiRxes Spins Out from A*Star with Novel qPCR Assay Platform for microRNA Analysis
Premium

Feb 27, 2014

Q&A: UMich's Muneesh Tewari on miRNAs as Cancer Biomarkers, ddPCR as Detection Method
Premium

May 10, 2012

Australian Team Finds Blood miRNA with Potential for Early Diagnosis of Malignant Mesothelioma
Premium

Breaking News
The Scan

Steps for Quick Review

The US Food and Drug Administration is preparing for the quick review of drugs and vaccines for the Omicron variant, according to the Wall Street Journal.

Moving Away From Using Term 'Race'

A new analysis finds that geneticists are using the term "race" in their papers less than in years past, as Science reports.

Point of the Program

The Guardian writes that some scientists have called the design of a UK newborn sequencing program into question.

Science Papers Present Multi-Omic Analysis of Lung Cells, Regulation of Cardiomyocyte Proliferation

In Science this week: a multi-omic analysis of lung cells focuses on RIT1-regulated pathways, and more.